InSysBio to participate in JuliaCon2024

events
Software
June 11, 2024

InSysBio announces its participation in JuliaCon 2024 which is to be held from July 9-13, 2024, at the Philips Stadion, Eindhoven, the Netherlands. Ivan Borisov, Senior Software Developer at InSysBio, will give a lightning talk:

July 12, 11:20–11:30 (Europe/Amsterdam), While Loop (4.2)

Ivan Borisov will highlight, "Practical identifiabilty based on Profile Likelihood is a crucial step in determining how well the parameters of a mechanistic model can be recovered from the experimental data. What packages are available to address this problem in Julia and what does Julia SciML community lack? How Profile likelihood-based methods can be applied to predictability analysis? The talk will cover the packages LikelihoodProfiler.jl, ProfileLikelihood.jl and the desirable improvements to Julia SciML ecosystem."

Moreover, InSysBio team is going to present 2 posters in frames of the Conference, namely:

July 10, 20:00–20:30 (Europe/Amsterdam), Function (4.1)

July 10, 21:00–21:30 (Europe/Amsterdam), Else (1.3)

About InSysBio

InSysBio is a group of Quantitative Systems Pharmacology (QSP) companies located in Limassol, Cyprus (INSYSBIO CY Ltd) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com

June 2021
MoTuWeThFrSaSu
 
1
2
1. 02 Jun 2021 16:46 InSysBio's student to defend diploma thesis Elena Vasileva, student of Lomonosov Moscow State University (MSU) has developed her diploma thesis in InSysBio and successfully passed its defense. Her diploma thesis entitled “Optimization of anti-CD47 therapeutic agent dosage using PK/PD modeling” was supervised by Oleg Demin Jr, Head of Oncology and Immuno-Oncology at InSysBio.
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
    
Upcoming Events
Tags
Latest News
10.09
InSysBio team to publish the new article in PSPJournal
04.09
InSysBio to launch Immune Response Template version 3.6.3 for QSP modeling
22.02
14th InSysBio’s Annual Internal Scientific Meeting
24.01
InSysBio to present the new Plugin for Sublime Text and Heta compiler Online
07.12
InSysBio to release public beta of fIVE Calculator